Orchard Therapeutics vs Sarepta
Orchard Therapeutics vs Sarepta, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Orchard Therapeutics is on 51/100 and Sarepta on 21/100.
Where each one leads
Orchard Therapeutics
- our overall score: 51/100 against 21/100
- agent readiness: 39/100 against 34/100
Sarepta
- domain rating: 68/100 against 60/100
- headcount: 1,162 against 248
- LinkedIn following: 138,724 against 54,964
At a glance
| Measure | Orchard Therapeutics | Sarepta |
|---|---|---|
| What it is | Gene therapy company developing treatments for rare inherited diseases. | Biopharmaceutical company focused on developing RNA-targeted therapies for rare genetic diseases. |
| Category | Biotech, MedTech, HealthTech, Genomics | Biotech, MedTech, HealthTech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2015 | Not published |
| Headquarters | Boston, United States | Cambridge, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Orchard Therapeutics | Sarepta |
|---|---|---|
| Employees | 248 | 1,162 |
| Open roles | Not published | 19 |
| Total funding | $125M | Not published |
| Latest round | IPO | Not published |
| LinkedIn followers | 54,964 | 138,724 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Orchard Therapeutics | Sarepta |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 51/100 | 21/100 |
| Traction | 60/100 | 20/100 |
| Team | 30/100 | Not published |
| Search visibility | 25/100 | 25/100 |
| Quality | 58/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | F (34/100) |
| Domain ratingLink authority, 0-100 | 60/100 | 68/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Orchard Therapeutics | Sarepta |
|---|---|---|
| Hosting | Not detected | AWS |
| CDN | Cloudflare | Cloudflare |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Jquery |
| Analytics | Google Tag Manager | Not detected |
What users say
| Measure | Orchard Therapeutics | Sarepta |
|---|---|---|
| Reddit sentimentThreads we track | Not published | 1 positive, 0 negative across 1 thread |
“Sarepta Therapeutics is a commercial-stage biopharmaceutical company that focuses on the discovery and development of RNA-targeted therapeutics, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. $SRP”r/
Orchard Therapeutics vs Sarepta: common questions
Which is better, Orchard Therapeutics or Sarepta?
On our 0-100 score Orchard Therapeutics rates higher (51/100 against 21/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do Orchard Therapeutics and Sarepta compare on the numbers?
Orchard Therapeutics leads on our overall score (51/100 against 21/100), agent readiness (39/100 against 34/100). Sarepta leads on domain rating (68/100 against 60/100), headcount (1,162 against 248), LinkedIn following (138,724 against 54,964).
What do real users say about Orchard Therapeutics and Sarepta?
Sarepta: 1 positive and 0 negative mentions across 1 Reddit threads we track.
Read the full Orchard Therapeutics review and pricing or the Sarepta review and pricing. You can also browse other Orchard Therapeutics alternatives we track.